NexgenRx Inc.

NexgenRx Inc.

May 30, 2012 17:26 ET

NexgenRx Announces Its 2012 First Quarter Results

TORONTO, ONTARIO--(Marketwire - May 30, 2012) - NEXGENRX INC. (TSX VENTURE:NXG) ("NexgenRx" or the "Corporation") is pleased to report financial results for its first quarter, ended March 31, 2012.

Revenue from transaction fees for the quarter ended March 31, 2012 was $1,099,109, representing an increase of 8% over the prior year period. The gross profit for the period was $840,898, an increase of $73,715 compared to the same quarter in 2011.

"The first quarter 2012 marks the start to another year of continued strengthening focused on new client revenue, organic growth and continued balance sheet improvement. I am pleased to announce that we achieved positive net income of $43,021, representing an increase of over $100,000 in comparison to the same period in 2011," stated Ron Loucks, President and CEO.

About NexgenRx

NexgenRx is a growing health benefits management company engaged in the design, management and administration of health benefit plans offered by employers and other plan sponsors for the benefit of their employees and plan members. More information on NexgenRx can be found at

Caution Regarding Forward-Looking Statements - This news release contains certain forward looking statements, including statements regarding the business and anticipated financial performance of the Corporation. These statements are subject to a number of risks and uncertainties. Actual results may differ materially from results contemplated by the forward-looking statements. When relying on forward-looking statements to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and should not place undue reliance on such forward-looking statements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the release.

Contact Information

  • NexgenRx Inc.
    Ronald C. Loucks
    President and CEO
    416.695.3393 x801

    NexgenRx Inc.
    Taba Merrikh
    Director of Finance
    416-695-3393 x803